InceptorBio

gainesville-fl

Inceptor Bio Announces $37 Million Series A Financing

Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, has announced the closing of a $37 million Series A financing led by Kineticos Ventures. Proceeds from the Series A financing will be used to advance Inceptor Bio’s CAR-T lead program to a Phase I clinical trial and continue development of its CAR-M and...